- Home
- AAME vs SNTI Comparison
AAME vs SNTI Comparison
Compare AAME & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAME
- SNTI
- Stock Information
- Founded
- AAME 1968
- SNTI 2016
- Country
- AAME United States
- SNTI United States
- Employees
- AAME N/A
- SNTI N/A
- Industry
- AAME Life Insurance
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- AAME Finance
- SNTI Health Care
- Exchange
- AAME Nasdaq
- SNTI Nasdaq
- Market Cap
- AAME 46.3M
- SNTI 39.6M
- IPO Year
- AAME N/A
- SNTI N/A
- Fundamental
- Price
- AAME $3.08
- SNTI $1.52
- Analyst Decision
- AAME
- SNTI Strong Buy
- Analyst Count
- AAME 0
- SNTI 2
- Target Price
- AAME N/A
- SNTI $8.50
- AVG Volume (30 Days)
- AAME 25.2K
- SNTI 140.6K
- Earning Date
- AAME 08-12-2025
- SNTI 08-07-2025
- Dividend Yield
- AAME 0.65%
- SNTI N/A
- EPS Growth
- AAME N/A
- SNTI N/A
- EPS
- AAME 0.10
- SNTI N/A
- Revenue
- AAME $198,977,000.00
- SNTI N/A
- Revenue This Year
- AAME N/A
- SNTI N/A
- Revenue Next Year
- AAME N/A
- SNTI $150.00
- P/E Ratio
- AAME $29.45
- SNTI N/A
- Revenue Growth
- AAME 6.98
- SNTI N/A
- 52 Week Low
- AAME $1.25
- SNTI $1.46
- 52 Week High
- AAME $3.37
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- AAME 78.68
- SNTI 30.93
- Support Level
- AAME $2.18
- SNTI $1.51
- Resistance Level
- AAME $2.38
- SNTI $1.62
- Average True Range (ATR)
- AAME 0.21
- SNTI 0.11
- MACD
- AAME 0.06
- SNTI 0.00
- Stochastic Oscillator
- AAME 76.09
- SNTI 13.64
About AAME Atlantic American Corporation
Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.